CAFs are characterized by the expression of activation markers such as αSMA (alpha smooth muscle actin), FAP (fibroblast activation protein) and FSP1 (fibroblast-specific protein 1) [31], and are a known source of ECM and soluble factors (e.g. growth and inflammatory factors) which impact tumour growth and progression. The gene discussed is S100A4; the disease is neoplasm.